SpaceX Is Poised to Reclaim a $190 Share Price by the End of 2026

SpaceX shares closed at $151.85 on Sept. 21, and the article argues they could reach $190 by year-end 2026, implying roughly 25% upside and a $2.58T market capitalization. At a constant approximately 19x 2027 sales multiple, that target would require 2027 revenue of about $136B, 25% above the $108.3B consensus but below the $151.96B highest analyst estimate. The bullish case rests on AI revenue, whose 2027 estimate reportedly rose from roughly $38B in June to $67B in September, alongside Q2 AI revenue growth of 247% to $2.6B and Starlink/connectivity revenue of $4.29B.

Analysis

The investable issue is estimate quality rather than the nominal upside target. A valuation supported by a revenue-reset thesis leaves little room for execution slippage: if incremental AI revenue carries lower gross margin than implied, or requires materially higher compute and network capex, EV/sales can compress even while reported sales beat. The reported acquisition-related share issuance also raises the bar for per-share value creation; future stock-funded acquisitions would make headline revenue growth a weak indicator of equity returns.

There is a material primary-source verification problem: the security’s listing status, segment disclosures, acquisition economics, contract backlog, and adjusted EBITDA bridge must be confirmed through exchange data and filed financial statements before underwriting any position. Contracted cloud sales are not equivalent to revenue or cash flow; cancellation terms, delivery period, customer concentration, and associated infrastructure commitments determine whether backlog warrants a premium multiple. Until that evidence is available, the positive narrative is not sufficiently differentiated to justify chasing a late-cycle estimate revision.

If validated, the next 1-3 month catalyst is another consensus upgrade driven by AI backlog conversion and connectivity subscriber economics; the 6-18 month risk is that capex intensity and depreciation expose substantially lower incremental returns than EBITDA suggests. A downside reset would likely be triggered by weaker bookings, rising deferred-delivery obligations, or guidance that separates AI revenue growth from AI gross-profit growth. NVDA is only a tangential read-through: incremental demand would matter only if customer disclosures establish that this workload uses Nvidia-accelerated infrastructure rather than internally designed or alternative silicon.

Key Decisions for Investors

• Do not initiate SPCX solely on this article. Place the name on an event-driven watchlist pending verification of listing, audited segment revenue, diluted share count, acquisition consideration, backlog terms, and capex/cash-flow disclosures; absent those data, there is no defensible risk/reward.
• If primary-source data confirm the disclosures, wait for the next earnings release and enter SPCX only after AI revenue, gross margin, and bookings all exceed consensus while diluted shares remain within 2% of the stated base. Size as a 1-2% tactical long with a 3-month horizon; exit on an AI bookings miss or a 300bp-plus gross-margin deterioration.
• For existing exposure, reduce into a valuation-driven rally if revenue estimates rise without matching free-cash-flow estimates. The falsification test for the bullish case is not sales alone: require stable or improving incremental FCF conversion as infrastructure spending scales over the next two reporting periods.
• Avoid using NVDA as a direct sympathy long from this item. Reassess only if SPCX discloses supplier concentration or accelerated-compute purchases; without that linkage, any NVDA trade is driven by broader AI demand rather than a company-specific catalyst.